Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

Trading Statement

14 Jul 2014 07:00

RNS Number : 1631M
Symphony Environmental Tech. PLC
14 July 2014
 



14 July 2014

 

 

Symphony Environmental Technologies Plc

 

("Symphony" "Group" or the "Company")

 

Trading update

 

Symphony Environmental Technologies Plc (AIM: SYM), global specialists in "making plastic smarter", with d2w controlled-life, d2p anti-bacterial and d2t anti-counterfeiting technologies, is pleased to announce the following activities in the first six months of 2014:

 

d2w Controlled-life Plastic Technology

• Major fertilizer company in Pakistan adopts d2w in all polythene bag liner applications

• Entered into a paid-for biodegradable development project with an $80 billion global consumer products corporation on one of their key product lines

Successful completion of first phase PET film development

• A number of high quality sales leads are moving towards completion from several market sectors including food, chemical and agricultural

• Progress is being made with enforcement in countries that have legislated in favour of d2w type technology

 

d2p Anti-microbial Plastic Technology

Entered into a development agreement with an $50 billion global polymer corporation

End-users launch new finished products incorporating d2p including air-conditioning pipes and filters, lavatory seats, garbage & clinical waste bags 

Achieved first sales in 2 out of 5 of the d2p product lines

Successful trials for post-harvest fruit applications an laboratory tests for rice and cheese packaging applications

Successful tests for foamed mattresses

FDA bread packaging application approval expected by the year-end 

FDA food contact approval in place for repeated use treated articles such as chopping boards and containers

Non-food applications approved for use in some EU countries and expected shortly in the USA

 

d2t Tag and Trace Technologies

The first order has been confirmed for a US user to combine d2t within a chemical formulation in order to monitor the addition rates and to detect counterfeiting. As a result of legislation changes and increase in enforcement activity, new interest and orders for d2detector have been placed.

 

Interim results

The Company expects to announce its interim results for the six months to 30 June 2014 in September. Revenues are expected to be approximately £3.3 million for the first half with administrative expenses significantly reduced following the cost reductions undertaken during 2013.

 

- Ends -

 

Contacts

Symphony Environmental Technologies Plc

 

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, FD

 

 

Cantor Fitzgerald Europe

 

Mark Percy (Corporate Finance)

Tel: +44 (0) 20 7894 7000

David Banks / Paul Jewell (Corporate Broking)

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGMNVMDGDZM
Date   Source Headline
28th Apr 20267:00 amRNSPre-Close Trading Update
7th Apr 20267:00 amRNS-RHSAC report
23rd Mar 20267:00 amRNSDirector/PDMR dealing - Bed & ISA
18th Feb 20268:28 amRNSNew consultancy agreement and grant of options
12th Jan 20267:00 amRNS-Rd2w Biodegradable Plastic Technology
22nd Dec 20257:00 amRNSCanadian govt policy shift re. single use plastics
22nd Dec 20257:00 amRNSCanadian govt policy shift re. single use plastics
22nd Dec 20257:00 amRNSHolding(s) in Company
22nd Dec 20257:00 amRNSHolding(s) in Company
18th Dec 20252:16 pmRNSStrategic MoU Signed with Arsan Global
18th Dec 20252:16 pmRNSStrategic MoU Signed with Arsan Global
17th Dec 20253:33 pmRNSTrading and Middle East operations update
28th Nov 20257:00 amRNS-RAlignment with BB-REG-NET's Recommendations
26th Nov 202510:25 amRNSExtension to Convertible Loan Agreements
10th Nov 20257:00 amRNS-RNew product launch, South Korea
29th Oct 20257:00 amRNS-RRoyal Society Study on Ocean Biodegradable Plastic
24th Oct 20257:00 amRNS-RCEO speaks at Argus Fertiliser Conference
16th Oct 20257:00 amRNS-RSuccessful attendance at the K-Show
30th Sep 20257:00 amRNSInterim Results for 6 Months Ended 30 June 2025
26th Sep 20257:00 amRNS-RCEO Speaks at US SPE Conference
19th Sep 20254:55 pmRNSEPA Ireland update
23rd Jul 20251:53 pmRNSResult of AGM
23rd Jul 20257:00 amRNSAGM Statement
8th Jul 202510:25 amRNSUpdate on Approval from the Republic of Ireland
25th Jun 20251:49 pmRNSHolding(s) in Company
23rd Jun 202512:37 pmRNSApproval of d2w products in Ireland
18th Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
12th Jun 20257:00 amRNSPreliminary Results
11th Jun 202510:15 amRNSChange of Subscription Amount
5th Jun 20257:00 amRNSChange of Equity Subscriber
14th May 202511:50 amRNSHolding(s) in Company
8th May 202510:35 amRNSEquity Subscription
10th Apr 20259:00 amRNSExtended Scientific Study on Microplastics in Soil
9th Apr 202510:00 amRNSTransfer of Shareholding and Assignment of CLAs
11th Mar 20257:00 amRNS-RStudy Findings - No Trace of Microplastics
10th Mar 20252:21 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNS-RRuling on Biodegradable Plastic Legislation
23rd Dec 202412:39 pmRNSOption amendments & grant of options
1st Nov 202411:15 amRNSGrant of Options
9th Sep 20247:00 amRNSInterim Results for 6 Months Ended 30 June 2024
23rd Aug 20247:00 amRNSNotice of Results and Investor Presentation
28th Jun 202412:49 pmRNSResult of AGM
28th Jun 20247:00 amRNSAGM Statement
6th Jun 20243:33 pmRNSPosting of Annual Report and Notice of AGM
6th Jun 20243:29 pmRNSPreliminary Results
23rd Apr 20244:36 pmRNSHolding(s) in Company
19th Apr 202411:16 amRNSResult of GM
3rd Apr 20242:00 pmRNSDirector dealing
28th Mar 20244:23 pmRNSResult of PrimaryBid Offer
28th Mar 20242:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.